NCT05616208View on ClinicalTrials.gov

Implantation of BioSphincter TM for Treatment of Severe Passive Fecal Incontinence

PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

November 2, 2022

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2027

Conditions

Fecal Incontinence

Interventions

BIOLOGICAL

Bioengineered Internal Anal Sphincter

Autologous Bioengineered Internal Anal Sphincter

Trial Locations (1)

23219

Virginia Commonwealth University Health Main Hospital (VCU), Richmond

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Cellf Bio LLC

INDUSTRY

NCT05616208 - Implantation of BioSphincter TM for Treatment of Severe Passive Fecal Incontinence | Biotech Hunter | Biotech Hunter